Genome-independent hypoxic repression of estrogen receptor alpha in breast cancer cells

BACKGROUND: About 75–80% of breast tumors express the estrogen receptor alpha (ER-α) and are treated with endocrine-target therapeutics, making this the premier therapeutic modality in the breast cancer clinic. However, acquired resistance is common and about 20% of resistant tumors loose ER-α expre...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Cancer
Asıl Yazarlar: Padró, Mercè, Louie, Raymond J., Lananna, Brian V., Krieg, Adam J., Timmerman, Luika A., Chan, Denise A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2017
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5358051/
https://ncbi.nlm.nih.gov/pubmed/28320353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3140-9
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller